PacificHealth Laboratories, Inc.
PHLI
OTC PK
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Revenue | -4.00% | -0.79% | -4.78% | -3.97% | -6.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.00% | -0.79% | -4.78% | -3.97% | -6.17% |
| Cost of Revenue | 2.51% | 2.06% | -2.83% | -2.73% | -12.64% |
| Gross Profit | -12.84% | -4.63% | -7.27% | -5.57% | 4.32% |
| SG&A Expenses | 2.95% | 6.33% | 2.79% | -5.35% | -18.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.87% | 4.36% | 0.11% | -3.39% | -14.74% |
| Operating Income | -112.03% | -114.92% | -196.20% | -6.32% | 65.21% |
| Income Before Tax | -74.98% | -40.18% | -18.99% | 36.13% | 66.16% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -74.98% | -40.18% | -18.99% | 36.13% | 59.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.98% | -40.18% | -18.99% | 36.13% | 59.44% |
| EBIT | -112.03% | -114.92% | -196.20% | -6.32% | 65.21% |
| EBITDA | -121.43% | -141.41% | -380.77% | -25.71% | 65.14% |
| EPS Basic | -40.37% | -7.21% | 6.76% | 51.60% | 62.47% |
| Normalized Basic EPS | -68.86% | -63.36% | -148.48% | 17.58% | 67.32% |
| EPS Diluted | -20.60% | 4.22% | 15.66% | 53.10% | 56.81% |
| Normalized Diluted EPS | -68.86% | -63.36% | -148.48% | 17.58% | 67.32% |
| Average Basic Shares Outstanding | 13.21% | 20.56% | 25.58% | 20.97% | 16.05% |
| Average Diluted Shares Outstanding | 12.64% | 19.91% | 25.57% | 21.55% | 16.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
